BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mathew R. Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1. World J Cardiol 2014; 6(8): 692-705 [PMID: 25228949 DOI: 10.4330/wjc.v6.i8.692]
URL: https://www.wjgnet.com/1949-8462/full/v6/i8/692.htm
Number Citing Articles
1
Xutong Sun, Qing Lu, Manivannan Yegambaram, Sanjiv Kumar, Ning Qu, Anup Srivastava, Ting Wang, Jeffrey R. Fineman, Stephen M. Black. TGF-β1 attenuates mitochondrial bioenergetics in pulmonary arterial endothelial cells via the disruption of carnitine homeostasisRedox Biology 2020; 36: 101593 doi: 10.1016/j.redox.2020.101593
2
Yohei Mineharu, Susumu Miyamoto. RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular StabilityFrontiers in Neurology 2021; 12 doi: 10.3389/fneur.2021.687088
3
Mirolyuba Ilieva, Shizuka Uchida. Potential Involvement of LncRNAs in Cardiometabolic DiseasesGenes 2023; 14(1): 213 doi: 10.3390/genes14010213
4
Francesco Giangregorio, Emilio Mosconi, Maria Grazia Debellis, Stella Provini, Ciro Esposito, Matteo Garolfi, Simona Oraka, Olga Kaloudi, Gunel Mustafazade, Raquel Marín-Baselga, Yale Tung-Chen. A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic ApproachesJournal of Clinical Medicine 2024; 13(19): 5880 doi: 10.3390/jcm13195880
5
Kirsten B. Dorschel, John E. Wanebo. Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseasesFrontiers in Neurology 2023; 14 doi: 10.3389/fneur.2023.661611
6
Dong‐xin Sui, Hui‐min Zhou, Feng Wang, Ming Zhong, Wei Zhang, Yun Ti. Cell death‐inducing DFF45‐like effector C gene silencing alleviates pulmonary vascular remodeling in a type 2 diabetic rat modelJournal of Diabetes Investigation 2018; 9(4): 741 doi: 10.1111/jdi.12768
7
Suvasini Lakshmanan, Matthew Jankowich, Wen‐Chih Wu, Siddique Abbasi, Alan R Morrison, Gaurav Choudhary. Association of plasma adiponectin with pulmonary hypertension, mortality and heart failure in African Americans: Jackson Heart StudyPulmonary Circulation 2020; 10(4): 1 doi: 10.1177/2045894020961242
8
Julie A Dillard, Claire Murray, Amit A Mathur. New Therapeutic Targets in Neonatal Pulmonary HypertensionNewborn 2022; 1(1): 158 doi: 10.5005/jp-journals-11002-0015
9
Hongyan Peng, Yunbin Xiao, Xicheng Deng, Jingfei Luo, Chenliang Hong, Xuping Qin. The Warburg effect: A new story in pulmonary arterial hypertensionClinica Chimica Acta 2016; 461: 53 doi: 10.1016/j.cca.2016.07.017
10
Gusty Rizky Teguh Ryanto, Ratoe Suraya, Tatsuya Nagano. Mitochondrial Dysfunction in Pulmonary HypertensionAntioxidants 2023; 12(2): 372 doi: 10.3390/antiox12020372
11
Yu G Birulina, V V Ivanov, E E Buyko, V V Bykov, A V Nosarev, V S Gusakova, S V Gusakova. Pulmonary vascular smooth muscle contraction in the rat model of metabolic syndromeIOP Conference Series: Earth and Environmental Science 2020; 548(4): 042036 doi: 10.1088/1755-1315/548/4/042036
12
Norbert F. Voelkel, Rasa Tamosiuniene, Mark R. Nicolls. Challenges and opportunities in treating inflammation associated with pulmonary hypertensionExpert Review of Cardiovascular Therapy 2016; 14(8): 939 doi: 10.1080/14779072.2016.1180976
13
Sophie Herbert, Robert M. R. Tulloh. Cardiovascular Genetics and Genomics2018; : 741 doi: 10.1007/978-3-319-66114-8_26